Santen Pharmaceutical Co's total assets for Q3 2025 were ¥398.31B, a decrease of -0.78% from the previous quarter. SNPHY total liabilities were ¥115.10B for the fiscal quarter, a -3.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.